Contineum Therapeutics (CTNM) has filed for 8,800,000 share IPO at $16-$18 per share.
Goldman Sachs, Morgan Stanley, Stifel and RBC Capital Markets will serve as underwriters.
Contineum Therapeutics (CTNM) has filed for 8,800,000 share IPO at $16-$18 per share.
Goldman Sachs, Morgan Stanley, Stifel and RBC Capital Markets will serve as underwriters.